Identifying Cancer Tissue of Origin using Plasma Whole Genome Sequencing

使用血浆全基因组测序识别癌症组织起源

• 批准号: 488922
• 负责人: Stein Lincoln
• 金额: $ 71.33万
• 依托单位: Ontario Institute for Cancer Research (Toronto, Ontario)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2027-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488922&lang=en
• 关键词: Artificial Intelligence; Cancer; Genomics; Liquid Biopsy; Machine Learning; Pwgs; Tumour Origin

Recent progress in cancer detection and treatment has led to a new issue. People who have survived cancer for many years now have a higher chance of getting a completely different type of cancer later on in life. This is called "multiple primary cancers."

癌症检测和治疗的最新进展导致了一个新的问题。那些在癌症中存活多年的人，在以后的生活中患上完全不同类型癌症的机会更高。这被称为“多原发癌。"